Comparable stake leader
John Paul DeJoria
SEC ownership of Telomir Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001971532.
Disclosed value leader
Bay Shore Trust
Comparable rows
34/47
Latest evidence
30 Jun 2026
- Public ticker
- TELO on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
John Paul DeJoria
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
34 of 47
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
John Paul DeJoria
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001971532
- Issuer location
- Miami, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Telomir Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
John Paul DeJoria
Disclosed value leader
Bay Shore Trust
Comparable rows
34/47
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 5.2%
13 rows are not safely comparable across share classes.
13D/G row: John Paul DeJoria
Showing 1-8 of 47 holder rows.
Quick read
John Paul DeJoria leads the comparable SEC ownership view at 5.2%.
34 of 47 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens John Paul DeJoria's linked filing trail.
Comparable ownership
Top 5
John Paul DeJoria
5.2%
MIRA PHARMACEUTICALS, INC.
5.1%
VANGUARD CAPITAL MANAGEMENT LLC
2.3%
GEODE CAPITAL MANAGEMENT, LLC
0.49%
BlackRock, Inc.
0.41%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 47 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| John Paul DeJoria |
13D/G
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
|
5.2%
|
$4,514,686
3,554,871 shares
|
+$393,536 | 30 Jun 2026 |
| MIRA PHARMACEUTICALS, INC. |
3/4/5
10%+ Owner
|
5.1%
|
$4,823,943
3,521,127 shares
|
— | 29 Sep 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
2.3%
|
$2,065,458
1,613,639 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.49%
|
$433,910
338,875 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
0.41%
|
$359,004
280,472 shares
|
— | 30 Jun 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.33%
|
$288,389
225,304 shares
|
— | 30 Jun 2026 |
| NORTHERN TRUST CORP |
13F
Company
|
0.09%
|
$78,761
61,532 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
Company
|
0.09%
|
$75,008
58,600 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 26 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to Telomir Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Bay Shore Trust
Net 12M change
$0
Latest report
03 Jun 2026
Recent insider transactions for Telomir Pharmaceuticals, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Erez Aminov | TELO | Non-Qualified Stock Options (right to buy) | Disposed to Issuer | -100% | -2,000,000 | 0 | 21 May 2026 | Direct | ||
| Erez Aminov | TELO | Non-Qualified Stock Options (right to buy) | Award | 2,000,000 | 2,000,000 | 21 May 2026 | Direct | |||
| Erez Aminov | TELO | Incentive Stock Options (right to buy) | Disposed to Issuer | -100% | -1,960,170 | 0 | 21 May 2026 | Direct | ||
| Erez Aminov | TELO | Incentive Stock Options (right to buy) | Award | 1,960,170 | 1,960,170 | 21 May 2026 | Direct | |||
| Matthew Pratt Whalen | TELO | Incentive Stock Options (right to buy) | Disposed to Issuer | -100% | -25,000 | 0 | 21 May 2026 | Direct | ||
| Matthew Pratt Whalen | TELO | Incentive Stock Options (right to buy) | Award | 25,000 | 25,000 | 21 May 2026 | Direct | |||
| Edward Clouston MacPherson | TELO | Incentive Stock Options (right to buy) | Disposed to Issuer | -100% | -25,000 | 0 | 21 May 2026 | Direct | ||
| Edward Clouston MacPherson | TELO | Incentive Stock Options (right to buy) | Award | 25,000 | 25,000 | 21 May 2026 | Direct | |||
| Matthew Paul del Giudice | TELO | Incentive Stock Options (right to buy) | Disposed to Issuer | -100% | -25,000 | 0 | 21 May 2026 | Direct | ||
| Matthew Paul del Giudice | TELO | Incentive Stock Options (right to buy) | Award | 25,000 | 25,000 | 21 May 2026 | Direct | |||
| Erez Aminov | TELO | Common Stock | Other | 7,319,710 | 7,319,710 | 22 Apr 2026 | Direct | |||
| Matthew Pratt Whalen | TELO | Non-Qualified Stock Options (right to buy) | Award | 50,000 | 50,000 | 16 Apr 2026 | Direct | |||
| Edward Clouston MacPherson | TELO | Non-Qualified Stock Options (right to buy) | Award | 50,000 | 50,000 | 16 Apr 2026 | Direct | |||
| Matthew Paul del Giudice | TELO | Non-Qualified Stock Options (right to buy) | Award | 50,000 | 50,000 | 16 Apr 2026 | Direct |
* marks a reported price that did not pass the local price check.